Company Search:
Advanced Search
Sponsored Links
Resapp Health Ltd Company Snapshot
Resapp Health Ltd operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Resapp Health Ltd with three other pharmaceutical manufacturers in Australasia: Dimerix Ltd (2016 sales of 45,311.00 Australian Dollars [US$34,989.15 ] ), Acuvax Limited (29,914.00 Australian Dollars [US$23,099.59 ] ), and Prana Biotechnology Limited (142,657.00 Australian Dollars [US$110,159.74 ] ).

Sales Analysis. Resapp Health Ltd reported sales of A$82,633.00 (US$63.81 thousand) for the fiscal year ending June of 2016. This represents a sharp decrease of 52.4% versus 2015, when the company's sales were A$173,427.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Resapp Health Ltd
  Stock Performance Chart for Resapp Health Ltd
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): .50
(Figures in Australian Dollars)
1 Week 5.3%   13 Weeks -1.0%  
4 Weeks 41.4%   52 Weeks 910.2%  
Resapp Health Ltd Key Data:
  Ticker: RAP Country: Australia
  Exchanges: Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2016 Sales 82,633
(Year Ending Jan 2017).
Employees: 3
  Currency: Australian Dollars Market Cap: 321,166,322
  Fiscal Yr Ends: June Shares Outstanding: 648,820,852
  Share Type: Ordinary Closely Held Shares: 235,563,379
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.